Neogen Corporation (NASDAQ:NEOG – Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 15th, there was short interest totaling 14,099,129 shares, a drop of 17.6% from the December 31st total of 17,105,312 shares. Based on an average daily volume of 6,000,603 shares, the days-to-cover ratio is presently 2.3 days. Approximately 6.5% of the shares of the company are short sold. Approximately 6.5% of the shares of the company are short sold. Based on an average daily volume of 6,000,603 shares, the days-to-cover ratio is presently 2.3 days.
Analyst Ratings Changes
Several analysts have commented on the stock. Piper Sandler restated a “neutral” rating and set a $10.00 price objective (up from $6.50) on shares of Neogen in a research note on Monday, January 12th. CJS Securities upgraded Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research report on Wednesday, December 10th. Wall Street Zen downgraded shares of Neogen from a “buy” rating to a “hold” rating in a research report on Saturday, January 10th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neogen in a research note on Monday, December 29th. Finally, Guggenheim restated a “buy” rating and issued a $12.00 price target (up from $8.00) on shares of Neogen in a research report on Friday, January 9th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $10.67.
Check Out Our Latest Research Report on Neogen
Institutional Investors Weigh In On Neogen
Neogen Stock Up 1.2%
NEOG stock traded up $0.13 during midday trading on Wednesday, hitting $10.40. The company’s stock had a trading volume of 1,807,695 shares, compared to its average volume of 4,423,418. Neogen has a 52-week low of $3.87 and a 52-week high of $10.90. The firm has a 50-day simple moving average of $7.91 and a 200-day simple moving average of $6.46. The company has a quick ratio of 2.80, a current ratio of 3.91 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $2.26 billion, a P/E ratio of -3.76 and a beta of 1.98.
Neogen (NASDAQ:NEOG – Get Free Report) last released its earnings results on Thursday, January 8th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.07 by $0.03. The firm had revenue of $224.69 million during the quarter, compared to analysts’ expectations of $208.50 million. Neogen had a positive return on equity of 2.14% and a negative net margin of 68.47%.Neogen’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.11 EPS. As a group, equities analysts forecast that Neogen will post 0.38 EPS for the current year.
About Neogen
Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.
In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.
Read More
- Five stocks we like better than Neogen
- Why This NYSE Biotech Matters in 2026
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
- This Company Surges Ahead as AI Marketing Fuels Record Revenue
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
